Of relevance
…..any potential sales of trofinetide in Canada will be combined with sales in the US for the purpose of determining Neuren’s entitlement to milestone payments and royalties.
Ann: Trofinetide accepted for Priority Review by Health Canada, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.73 |
Change
0.720(4.23%) |
Mkt cap ! $2.205B | |||
| Open | High | Low | Value | Volume |
| $17.48 | $18.44 | $17.40 | $11.67M | 652.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14 | $17.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.74 | 116 | 3 |
View Market Depth
| Last trade - 14.25pm 07/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |